Spectrum’s Autism Drug Trial Tracker
Recent articles
Autism Drug Trial Tracker
Explore hundreds of clinical trials with our interactive tool.
Autism Drug Trial Tracker
Explore hundreds of clinical trials with our interactive tool.
Introducing Spectrum’s Autism Drug Trial Tracker
The tool provides interactive, curated information on more than 200 clinical trials for autism and related conditions.
Introducing Spectrum’s Autism Drug Trial Tracker
The tool provides interactive, curated information on more than 200 clinical trials for autism and related conditions.
Autism Drug Trial Tracker: User Guide
Learn how to use the Autism Drug Trial Tracker, with specific examples and detailed explanations for each data column.
Autism Drug Trial Tracker: User Guide
Learn how to use the Autism Drug Trial Tracker, with specific examples and detailed explanations for each data column.
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.